BCBS Says Generic Xyrem Delay Was Antitrust Scheme
By Adam Lidgett · July 14, 2020, 8:51 PM EDT
Blue Cross Blue Shield Association has accused Jazz Pharmaceuticals in California federal court of paying off generic-drug makers to delay their rival versions of the pharmaceutical giant's brand name narcolepsy drug...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login